Chennai-based pharma major Orchid Chemicals and &amp; Pharmaceuticals  has received a permission from Canadian drug regulator to sell combination antibiotic piperacillin-tazobactam injection in that country.


</p><tr><td><p class='TableClas'></p><P class='TableClas'> <DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>In communique to NSE company has said, company hopes to launch the product by July.&nbsp;&nbsp; </P>
</p><p class='TableClas'>Though market size for the drug is small around $ 22 million, company hopes to have strong foothold in the Canadian market as there are only two to three existing players in the market. <BR></P></p></table>


Chennai-based pharma major Orchid Chemicals and & Pharmaceuticals  has received a permission from Canadian drug regulator to sell combination antibiotic piperacillin-tazobactam injection in that country.

Orchid gets permission to sell drug in Canada

Also Read

Birla Cotsyn to come up with an IPO

Mittal buys third major property in London

Gail board recommends 1:2 bonus issue

Wipro raises Rs 1,400 cr via external borrowings

Tata Power plans Rs 25,000-cr capex

Explore News